VBI Vaccines Appoints Christopher McNulty as Chief Financial Officer and Head of Business Development
August 15, 2018 08:00 ET
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Aug. 15, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI”), a commercial-stage biopharmaceutical company, today announced the appointment of Christopher McNulty as...